Portfolio Update

RNS Number : 2383U

Intl. Biotechnology Trust PLC

20 October 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 September 2017

Net Assets	£241m
Net Assets per share	642p
Share price	605p
Total value of unquoted investments	£17m
Total number of portfolio companies	93
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	8.1
Biogen	6.9
Regeneron	5.7
Vertex	4.2
Alexion	4.0
Shire	3.6
Incyte	3.2
Gilead	3.1
Acadia	2.8
Adamas	2.6
	-----------
Total	44.2

Geographical Allocation	% NAV
US & Canada	86
Europe & UK	14
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	45
Mid Cap =USD1-10BN	31
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	35
Rare diseases	15
CNS	13
Ophthalmology	8
Inflammation	8
Infectious Diseases	5
Metabolic	5
Medtech	2
Other	9
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

20 OCTOBER 2017

 

END

 

 

PFUBXBDGISDBGRG